Planning and Evaluation supports the strategic planning of the Comprehensive Cancer Center of Wake Forest University (CCCWFU). Operations of the CCCWFU are entrusted to specific Boards and Committees, which serve as administrative """"""""planning and evaluation"""""""" units of the Center. The leadership of the CCCWFU uses both internal and external committees and boards to obtain substantive advice in order to continuously develop, modify, and evaluate the plans of the Center. Internal: Our internal meetings are an important part of developing the strategic direction for the Center and evaluating the performance. We convene standing meetings of the Internal Advisory Board, the Program Directors, the Shared Resource Directors, and clinical research oversight committees. In addition, each Program and Center of Excellence (as part of the Clinical Research Program) holds regularly scheduled meetings for their entire membership. External: We also are highly engaged with external boards and review groups. Our external Board of Scientific Councilors (BSC) has served the Cancer Center with leadership and insight and represents an essential element of independent review and external advice for the Cancer Center. The BSC meets yearly as a group to review the CCCWFU in its entirety, evaluating each Program within the broader context of the Center. In addition to this formal meeting, the Center Director, Dr. Frank Torti, and other members of the leadership team access Board members on many other occasions throughout the year. The individual research Programs also have external reviewers who provide feedback specific to the themes of the Programs and the plans for future directions. The full-day retreats are designed to give the reviewer in-depth information on the progress of research.

Public Health Relevance

The planning and evaluation component of our Center is the catalyst to enhance our cancer research and evaluate new opportunities. It is essential that we have our various internal and external committees and boards to ensure the trajectory of our scientific foci are delivering the highest quality scientific discoveries to enhance patient care, which is our ultimate goal.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA012197-39
Application #
8617232
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
39
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Haas, Karen M; Johnson, Kristen L; Phipps, James P et al. (2018) CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens. J Immunol 200:1671-1681
Park, Sun H; Keller, Evan T; Shiozawa, Yusuke (2018) Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. Calcif Tissue Int 102:152-162
Suo, Xubin; Eldridge, Brittany N; Zhang, Han et al. (2018) P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes. ACS Appl Mater Interfaces 10:33464-33473
Widner, D Brooke; Park, Sun H; Eber, Matthew R et al. (2018) Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy. Curr Osteoporos Rep 16:596-602
Liu, Liang; Ruiz, Jimmy; O'Neill, Stacey S et al. (2018) Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Mol Cancer 17:81
Sirkisoon, Sherona R; Carpenter, Richard L; Rimkus, Tadas et al. (2018) Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene 37:2502-2514
Goyal, Amrita; Carter, Joi B; Pashtan, Itai et al. (2018) Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: A retrospective study. J Am Acad Dermatol 78:408-410
Su, Weijun; Hong, Lixin; Xu, Xin et al. (2018) miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways. Oncogene 37:5618-5632
Miller Jr, David P; Denizard-Thompson, Nancy; Weaver, Kathryn E et al. (2018) Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients: A Randomized Controlled Trial. Ann Intern Med 168:550-557
Bonin, Keith; Smelser, Amanda; Moreno, Naike Salvador et al. (2018) Structured illumination to spatially map chromatin motions. J Biomed Opt 23:1-8

Showing the most recent 10 out of 548 publications